Chromatin has historically been considered to exist in one of two distinct states: euchromatin or heterochromatin. Euchromatin is generally thought to be gene rich, transcriptionally active and associated with an open and accessible conformation, whereas heterochromatin is comparatively gene poor, highly condensed and refractory to the transcription machinery 1 . Heterochromatin has traditionally been considered to occur in two distinct types: that marked with Lys27-trimethylated histone H3 (H3K27me3), which is dynamically deposited during development 2 , and that marked with Lys9-trimethylated H3 (H3K9me3), which is typically found at repeat-rich regions 3 .
A remarkable property of H3K9me3-marked heterochromatin is that it can 'spread' along the arm of a chromosome, thus resulting in the epigenetic repression of an active gene in the vicinity of a heterochromatic domain 4 . This phenomenon gives rise to chromosomal position effects, a term referring to differences in expression when an identical gene is positioned at different sites in the genome 5, 6 . We have previously exploited the near-haploid KBM7 cell line 7, 8 to identify genes required for position-effect variegation in human cells 9 . By isolating a population of cells that displayed epigenetic repression of an integrated green fluorescent protein (GFP) reporter construct and screening for mutants in which this repression was alleviated, we identified four genes encoding proteins essential for transgene repression: the histone lysine methyltransferase SETDB1 (ref. 10) and the human silencing hub (HUSH) complex subunits TASOR, MPP8 and Periphilin 9 . Through the chromodomain of MPP8 (ref. 11) , HUSH preferentially localizes to genomic loci rich in the repressive histone modification H3K9me3. HUSH-mediated recruitment of the methyltransferase SETDB1 to these sites results in the 'writing' of additional H3K9me3, thereby mediating the spreading of heterochromatin across incoming transgenes 9 . The HUSH complex also plays a critical role in endogenous heterochromatin maintenance, as deletion of HUSH subunits results in decreased H3K9me3 at hundreds of genomic loci 9 and in early embryonic lethality in mice 12, 13 .
HUSH-mediated silencing is achieved through the reading and writing of H3K9me3. However, to understand how the deposition of this modification ultimately results in epigenetic repression, knowledge of the full complement of HUSH components is essential. Although our original haploid screen identified the core HUSH complex members and SETDB1, our recent examination of the efficacy of the haploid gene-trap approach has suggested that such screens are unlikely to achieve saturation 14 . HUSH-mediated silencing may therefore require additional factors not identified by the original gene-trap screen, and, in support of this idea, we recently identified ATF7IP as an additional factor required for HUSH-mediated repression, by using a proteomic approach 15 .
With the aim of identifying additional genes required for transgene silencing by the HUSH complex, we carried out a genome-wide forward genetic screen using CRISPR-Cas9 technology 16, 17 . The CRISPR screen highlighted one additional gene as being critical for HUSHmediated repression: microchidia CW-type zinc-finger 2 (MORC2). Here, we found that HUSH recruits MORC2 to heterochromatic sites, where its ATPase activity is required to mediate transgene silencing. Loss of MORC2 results in chromatin decompaction at HUSHtarget loci, concomittant with a loss of H3K9me3 and transcriptional Hyperactivation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 1 0 3 6 VOLUME 49 | NUMBER 7 | JULY 2017 Nature GeNetics A r t i c l e s derepression. Alterations in residues in the ATPase domain of MORC2 have recently been implicated in CMT disease, one of the most frequently inherited neurological disorders. We found that the most common of these alterations (p.Arg252Trp) results in hyperactivation of HUSH-mediated silencing in neuronal cells. Overall, this study identifies a critical role for MORC2 in HUSH-mediated repression and provides further insight into the mechanisms underlying HUSH complex function in health and disease.
RESULTS

MORC2 is essential for HUSH-mediated silencing
The rapid emergence of CRISPR-Cas9-mediated genome editing technologies allowed us to reevaluate the set of genes required for HUSH-mediated transgene silencing (Fig. 1a) . The Cas9 nuclease was expressed in the same population of GFP dim KBM7 cells stably expressing epigenetically repressed transgenes that we have used previously 9 , and genome-wide CRISPR-mediated mutagenesis was performed with the GeCKO v2 single guide RNA (sgRNA) library 18 . Two rounds of fluorescence-activated cell sorting (FACS) were used to enrich for GFP bright cells in which epigenetic repression of the GFP reporter transgene was relieved (Fig. 1b) , and sgRNA abundance in the selected GFP bright cells compared with the unselected library of mutagenized cells was quantified by Illumina sequencing (Fig. 1c and  Supplementary Fig. 1a) .
Five genes are known to encode proteins critical for HUSHmediated transgene repression: the three HUSH complex subunits TASOR, MPP8 and Periphilin 9 , plus the histone methyltransferase SETDB1 (ref. 9 ) and its accessory factor ATF7IP 15 . Three of these positive controls, MPP8, SETDB1 and ATF7IP, were successfully identified by the CRISPR screen; however, TASOR and Periphilin were not significantly enriched, thus suggesting that the screen did not reach saturation ( Fig. 1c and Supplementary Fig. 1a) . Through individual CRISPR-Cas9-mediated gene disruption experiments, we assessed potential roles for the other most significantly enriched genes in transgene silencing (Supplementary Fig. 1b) . The results revealed an essential role for one additional gene, MORC2, a finding that we corroborated in an independent HeLa-cell clone bearing a HUSH-repressed GFP reporter construct 9 (Fig. 1d,e) . With the exception of SEL1L, which mediates the degradation of the GFP reporter at the protein level 14 , we were unable to validate any of the additional candidate genes (Supplementary Fig. 1b) . Therefore, the genome-wide CRISPR screen identified a single novel gene, MORC2, encoding a bona fide factor required for HUSHmediated transgene repression. All genes targeted by sgRNAs are arranged alphabetically by name along the x axis, and statistical significance, as determined by the RSA algorithm, is plotted on the y axis. Bubble size is proportional to the number of active sgRNAs for each gene. Colored bubbles represent validated hits; the HUSH complex subunits TASOR and Periphilin (black) did not reach statistical significance, whereas SEL1L (orange) is involved in the degradation of the GFP-fusion protein 14 . A fully annotated plot is provided in supplementary Figure 1 . 20, 21 . MORC2 encodes a protein containing a GHKL-type ATPase, comprising the N-terminal ATPase domain plus an associated ribosomal protein S5-like domain, which is followed by two putative histone-binding modules: a CW-type zinc-finger and a chromo-like domain (Fig. 2a) . To assess which of these domains are required for the function of MORC2 in HUSHmediated repression, we performed a series of genetic complementation experiments in a MORC2-knockout HeLa clone (Fig. 2b-d and Supplementary Table 1 ). Whereas exogenous expression of fulllength MORC2 or a MORC2 mutant lacking the chromo-like domain resulted in rerepression of the GFP reporter, deletion of both ATPase domains, the S5-like domain alone or the CW-type zinc-finger abolished MORC2 activity (Fig. 2e,f) . Sequence analysis also predicted the presence of three coiled-coil domains (denoted CC1, CC2 and CC3) (Fig. 2a) ; deletion of any one of these domains also abrogated MORC2 function (Fig. 2e,f) . Thus, the MORC2 ATPase domain, CW-type zinc-finger and coiled-coil domains, but not the chromolike domain, appeared to be critical for HUSH-mediated epigenetic repression, with the caveat that although these mutant proteins were expressed in cells (Fig. 2f) , we are unable to verify that they were correctly folded.
MORC2 interacts with the HUSH complex
The genetic association between MORC2 and the HUSH complex suggested that MORC2 might physically interact with HUSH subunits. We were readily able to detect an interaction between V5 epitopetagged MORC2 immunoprecipitated from HeLa nuclei and the HUSH subunits TASOR and MPP8 (Fig. 3a) . To delineate the region of MORC2 responsible for this interaction, we repeated this assay with a series of V5-tagged N-and C-terminal-truncation mutants of MORC2 (Supplementary Table 1 ). The results suggested that the second coiled-coil domain (CC2) of MORC2 (residues 548-603) was likely to be essential for this interaction ( Supplementary Fig. 2a-c) . Fig. 2d ), and deletion of MORC2 did not prevent the interaction between SETDB1 and HUSH ( Supplementary Fig. 2e ), thereby suggesting independent recruitment of these two potential effector proteins by the HUSH complex. However, like SETDB1, MORC2 did not appear to be a constitutive member of the HUSH complex, because, in contrast to loss of TASOR, MPP8 or Periphilin 9 , loss of MORC2 did not affect the protein levels of HUSH subunits ( Supplementary Fig. 2f ) or their localization to chromatin ( Supplementary Fig. 2g ).
The HUSH complex recruits MORC2 to heterochromatic loci
To ascertain the physiological relevance of the association between MORC2 and the HUSH complex, we performed chromatin immunoprecipitation followed by deep sequencing (ChIP-seq).
Immunoprecipitation of a V5-tagged MORC2 construct expressed in MORC2-knockout cells revealed two modes of MORC2 binding to chromatin ( Fig. 3b) : a broad distribution across the bodies of genes located in H3K9me3-marked heterochromatin (Fig. 3c,d and Supplementary Fig. 3a ) and a series of discrete peaks at transcription start sites (TSSs) (Fig. 3e,f and Supplementary Fig. 3b ). Comparing the occupancy of MORC2 with that of endogenous TASOR revealed a substantial overlap between the heterochromatic regions bound by MORC2 and those occupied by the HUSH complex ( Fig. 3c,d ). Indeed, MORC2 localization to these heterochromatic sites was dependent on the HUSH complex, as MORC2 occupancy was lost in cells lacking all three HUSH subunits ( Fig. 3c,d ). Thus, these data sets revealed HUSH-dependent recruitment of MORC2 to heterochromatic loci marked by H3K9me3. The functional relevance of MORC2 recruitment In total, 4,500 peaks of V5-MORC2 occupancy were detected, most of which fell into two categories: binding sites in heterochromatin marked by H3K9me3 (purple; left) and binding sites at TSSs (green; right). (c,d) The HUSH complex recruits MORC2 to heterochromatic sites marked by H3K9me3. TASOR and MORC2 occupancy was observed at a range of sites marked by H3K9me3; MORC2 recruitment at these sites was dependent on HUSH, as V5-MORC2 occupancy was lost in cells lacking all three HUSH subunits 9 (HUSH KO). Three example loci are shown in c, and summary data across all loci are shown in d. Full ChIP-seq traces including input DNA controls are shown in supplementary Figure 3a . For box plots: center line, median; box limits, upper and lower lower quartiles; whiskers, 1.5× interquartile range. (e,f) MORC2 recruitment to transcriptional start sites is independent of the HUSH complex. MORC2 occupancy was observed at a large number of TSSs marked by the H3K4me3 histone modification. This occupancy was independent of the HUSH complex, because TASOR occupancy was not observed at these sites, and MORC2 occupancy was maintained in cells lacking HUSH subunits. Three example loci are shown in e, and summary data across all loci are shown in f. Full ChIP-seq traces including input DNA controls are shown in supplementary Figure 3b. to TSSs remains unclear, but this recruitment was not dependent on the HUSH complex (Fig. 3e,f) and did not involve recognition of Lys4-trimethylated H3 (H3K4me3) by the CW domain of MORC2 (ref. 22) (Supplementary Fig. 4 ), as has been demonstrated for the CW domains of MORC3 and MORC4 (refs. 23,24) .
In further support of an association between HUSH and MORC2, we also found that the HUSH complex regulated the expression of MORC2. Knockout of HUSH subunits or SETDB1 resulted in an increase in MORC2 expression, as measured by quantitative reverse transcription PCR (qRT-PCR) (Supplementary Fig. 2h ). In addition, our ChIP-seq data demonstrated both TASOR occupancy and HUSH-dependent recruitment of MORC2 to an H3K9me3-rich site in the MORC2 promoter, thus further suggesting a direct feedback loop (Supplementary Fig. 2i ).
MORC2 loss results in chromatin decompaction at HUSH loci
The catalytic activity of the MORC2 ATPase domain allows MORC2 to remodel nucleosomal templates in vitro 25 . Therefore, we hypothesized that ATP hydrolysis by MORC2 might be required to alter chromatin architecture at HUSH-target sites in vivo. To directly test the functional requirement for MORC2 ATPase activity in HUSH-mediated silencing, we carried out further genetic complementation assays in MORC2-knockout HeLa cells (Fig. 4a) . Whereas exogenous expression of wild-type MORC2 restored HUSH function and resulted in the rerepression of the GFP reporter construct, MORC2 variants bearing point substitutions in the critical residues of the ATPase domain required for ATP binding (p.Asn39Ala) or hydrolysis (p.Asp68Ala) 25 were nonfunctional (Fig. 4a,b) .
If the ATPase activity of MORC2 were required to mediate chromatin compaction during HUSH-mediated repression in vivo, disruption of MORC2 would result in a more open chromatin structure at sites of HUSH activity. Assay for transposase-accessible chromatin with highthroughput sequencing (ATAC-seq) is currently a leading method to assay changes in chromatin accessibility in vivo 26 , but our attempts to exploit this technology to examine potential chromatin decompaction in MORC2-knockout HeLa cells were hampered by a large proportion of contaminating mitochondrial reads 27 and insufficient coverage of the heterochromatic portions of the genome at which 10,000,000 20,000,000 30,000,000 40,000,000 50,000,000 Position (bp) Supplementary Fig. 5a,b) . We therefore developed a new approach, differential viral accessibility (DIVA), to examine changes in chromatin accessibility in vivo. DIVA is conceptually similar to ATAC-seq, but, rather than identifying transposon integration sites to probe accessible chromatin, DIVA maps the integration sites of exogenous lentiviruses ( Fig. 4c and Supplementary Fig. 5c ).
In contrast to the Tn5 transposase, which preferentially integrates near TSSs, HIV-1-derived lentiviral vectors preferentially target gene bodies 28 .
We used DIVA to compare chromatin accessibility in wild-type and MORC2-null HeLa cells. Approximately 20 million independent viral integration sites were mapped in each cell type, and the two data sets were then compared to identify loci exhibiting significantly greater numbers of integrations in the MORC2-knockout cells compared with the parental wild-type cells (Fig. 4c and Supplementary Fig. 5d-g ).
Considering the genome as a series of 10-kb windows, we identified 278 loci exhibiting chromatin decompaction after knockout of MORC2 ( Fig. 4d and Supplementary Table 2) . A large proportion of these loci were heterochromatic sites at which TASOR or MORC2 occupancy was observed by ChIP-seq (Fig. 4e) . Notably, many of these loci contained genes encoding zinc-finger (ZNF) proteins (ZNF genes ; Fig. 4f) ; for example, on chromosome 19, which is rich in ZNF genes, a striking concordance was observed between the positions of clusters of ZNF genes and the loci exhibiting decompaction in MORC2-knockout cells (Fig. 4g) . Using an orthogonal technique based on micrococcal nuclease sensitivity, we validated increased chromatin accessibility in MORC2-knockout cells at four example loci containing ZNF genes (Supplementary Fig. 6 ).
MORC2 loss results in decreased H3K9me3 and transcriptional derepression
We also sought to assess the relationship between MORC2-dependent changes in chromatin accessibility and H3K9me3 deposition. We found that loss of MORC2 in HeLa cells resulted in a decrease in H3K9me3 at most loci exhibiting chromatin decompaction after MORC2 knockout (Fig. 5a,b and Supplementary Fig. 7a) , thus supporting the idea that chromatin decompaction results in a concomitant decrease in H3K9me3 levels. In agreement with the functional association between MORC2 and the HUSH complex, 906 of the 918 loci (99%) that we previously found to lose H3K9me3 after deletion of any of the three HUSH subunits 9 also showed decreased H3K9me3 levels in MORC2-knockout cells (Fig. 5c) . At most of these sites, H3K9me3 deposition was dependent on the HUSH-associated methyltransferase SETDB1 (Supplementary Fig. 7a,b) . 
A r t i c l e s
Finally, we considered the effect of chromatin decompaction at these sites on gene expression. In addition to a decrease in H3K9me3, we found that decompaction after knockout of MORC2 resulted in an increase in the mean expression level of the 89 genes within these loci (Fig. 5d) , with 42 genes (47%) displaying a >1.2-fold increase in expression. Furthermore, of all the 190 genes significantly upregulated after MORC2 knockout (Fig. 5e) , ZNF genes were the most significantly enriched functional group (Fig. 5f) . In agreement with a repressive role for MORC2, most of the upregulated genes were direct targets of TASOR and/or MORC2, (Supplementary Fig. 7c,d) , and many also exhibited a loss of H3K9me3 and decompaction after MORC2 knockout (Supplementary Fig. 7e ). In contrast, ablation of MORC2 did not result in a global transcriptional change across genes exhibiting HUSH-independent MORC2 occupancy at their TSSs (Supplementary Fig. 7f) . Altogether, these data support a model in which loss of MORC2 results in chromatin decompaction, a loss of SETDB1-mediated H3K9me3 deposition and transcriptional derepression at HUSH-target sites.
p.Arg252Trp CMT substitution in MORC2 hyperactivates HUSH silencing
Five independent studies have recently reported that dominant mutations in the sequence encoding the ATPase domain of MORC2 can cause axonal CMT disease [29] [30] [31] [32] [33] (Fig. 6a) . We focused on understanding the functional effects of the most prevalent alteration, which results in an arginine-to-tryptophan substitution at residue In agreement with the genetic data suggesting a gain-of-function mechanism underlying the pathogenicity of the mutations, MORC2 with the p.Arg252Trp substitution did encode a functional protein capable of restoring HUSH-mediated transgene repression in MORC2-knockout HeLa cells (Fig. 6b,c) . Moreover, the p.Arg252Trp mutant consistently outperformed the wild-type protein, thus resulting in enhanced rerepression of the GFP reporter. Indeed, despite being expressed at a lower level that the wild-type protein, the p.Arg252Trp substitution both accelerated the rate of reporter rerepression and enhanced the overall degree of reporter repression observed (Fig. 6d and Supplementary Fig. 8 ). To verify that this effect was also present at endogenous genes targeted by HUSH and MORC2, we performed RNA-seq analysis to compare the transcriptome of MORC2-knockout HeLa cells reconstituted with wildtype MORC2 with that of the p.Arg252Trp mutant ( Supplementary  Fig. 9 ). In agreement with the results from the reporter assays, we found that the p.Arg252Trp substitution resulted in the hyper-repression of MORC2-target genes (Supplementary Fig. 9 ).
The mutant MORC2 proteins exert a dominant effect in CMT patients, driving the disease phenotype when coexpressed with a wildtype MORC2 allele. Therefore, we considered whether the p.Arg252 mutant MORC2 could hyper-repress HUSH-target genes when it was expressed together with the wild-type protein in MORC2-sufficient cells. First, we found that overexpression of p.Arg252Trp MORC2, but not wild type, resulted in hyper-repression of a HUSH-responsive 'GFP dim ' HeLa reporter clone that exhibited weak expression at steady state (Fig. 6e) . We then considered whether this effect might also occur at endogenous genes in neuronal cells. Transcriptome analysis of SK-N-SH neuroblastoma cells by RNA-seq (Fig. 6f) showed that overexpression of either wild-type or p.Arg252Trp MORC2 enhanced repression at example HUSH-target sites (Fig. 6g) ; however, this effect was substantially greater with the p.Arg252Trp mutant, although it was expressed at ~7.5-fold lower levels than the wild-type protein (Fig. 6h) . Indeed, of the 91 genes significantly overrepressed by p.Arg252Trp protein compared with the wild-type protein, 31 (34%) were ZNF genes marked by H3K9me3 (Fig. 6i) . Overall, these data suggested that the p.Arg252Trp substitution in MORC2 hyperactivates HUSH-mediated epigenetic repression, thus resulting in overrepression of HUSH-target genes in neuronal cells.
DISCUSSION
The recently identified HUSH complex is an important regulator of mammalian heterochromatin that is critical for silencing of newly integrated retroviruses 9 and for normal embryonic development 12, 13 . Here, through a genome-wide CRISPR-Cas9-mediated forward genetic screen, we identified MORC2 as an additional accessory member of the HUSH complex. MORC2 is recruited by the HUSH complex to heterochromatic loci, where its ATPase activity is essential for HUSH-mediated silencing. Exploiting a new method, DIVA, we found that loss of MORC2 resulted in chromatin decompaction at these sites, which was accompanied by a decrease in H3K9me3 levels and transcriptional derepression. Furthermore, we found that the most commonly identified CMT disease alteration in the MORC2 ATPase domain, p.Arg252Trp, resulted in hyperactivation of HUSHmediated repression at heterochromatic loci.
Previously we identified the HUSH complex through a gene-trap mutagenesis screen in the near-haploid KBM7 human cell line 9 . The rapid emergence of CRISPR-Cas9-mediated genome editing technologies allowed us to reexamine the complement of genes required for transgene repression, using a genome-wide library of sgRNAs to create the starting pool of mutant cells. The results of the two screens proved to be complementary, because, although the CRISPR screen did not identify two of the core HUSH complex subunits detected by the original haploid gene-trap screen, it did reveal an essential role of one additional gene, MORC2 (Fig. 1) . The CRISPR screening technique is therefore a powerful alternative to the haploid gene-trap approach 14 , and, given the considerable interest in designing more efficacious guide RNA libraries [34] [35] [36] , it is likely that the accuracy of such genome-wide CRISPR screens will continue to improve.
In humans, the MORC protein family comprises four proteins (MORC1-4) plus the more divergent SMCHD1 (ref. 19 ). MORC1 represses transposable elements in the male mouse germ line 21 , and MORC2 has been implicated in the response to DNA damage 25 , but the molecular function of the mammalian MORC family members remains largely uncharacterized. All MORC proteins share a similar domain architecture comprising an N-terminal GHKL-type ATPase domain and a CW-type zinc-finger, but their functions are likely to be distinct. For example, the inability of the CW-type zinc-fingers of MORC1 and MORC2 to recognize methylated H3K4 suggests a different mode of recruitment to chromatin compared with those of MORC3 and MORC4 (ref. 22) , whereas only alterations in MORC2 are associated with CMT disease [29] [30] [31] [32] [33] . A key challenge, therefore, is to elucidate how MORC proteins are recruited to chromatin and to determine their effects on nucleosomal architecture at target sites. Here, we found that HUSH regulates the localization of MORC2 to target sites on chromatin, and that the ATPase activity of MORC2 plays a critical role in altering chromatin architecture at these sites during HUSH-mediated silencing.
The ATPase activity of MORC2 is required to drive nucleosome remodeling in vitro 25 ; furthermore, we found this activity to be essential for transgene silencing by the HUSH complex in vivo (Fig. 4a,b) . Therefore, it followed that the remodeling activity of MORC2 might be required to alter chromatin architecture at these sites and consequently promote gene silencing. Although ATAC-seq has been widely used to study the degree of chromatin 'opening' at TSSs, we found it unsuitable to probe decompaction of heterochromatic regions, owing to the low proportion of transposon integrations into such sites. Instead of mapping transposon integration sites, DIVA examines the integration preferences of exogenous lentiviruses to probe accessible chromatin. Lentiviruses preferentially target the bodies of genes 28 , and indeed our data showed that this approach affords far greater coverage of the heterochromatic sites at which the HUSH complex functions. We therefore anticipate that DIVA may prove to be a useful approach to interrogate changes in heterochromatin structure in vivo in other experimental systems. However DIVA may not be suitable for comparisons between nonisogenic cell lines, because it may be impossible to control for differences in the abundance or activity of other factors influencing viral integration preferences. Furthermore DIVA relies on high-efficiency transduction with lentiviral vectors, which may not be achievable in all cell types, and, in contrast to the simplicity of ATAC-seq, requires a more involved protocol for the preparation of sequencing libraries to map virus-genome junctions.
Our application of DIVA to compare wild-type and MORC2-null cells revealed that loss of MORC2 resulted in chromatin decompaction at HUSH-target sites. The repetetive ZNF gene family was the most enriched functional group. Many of the ZNF genes are located in clusters covered by high levels of H3K9me3, a mark also found in other repetitive regions of the genome, including centromeresA r t i c l e s and tandem repeats. Although we did not observe decompaction of these additional repetitive regions after MORC2 disruption, we do not know how well DIVA might capture these other sites of repressive heterochromatin. Further experiments will be needed to address the specific physiological role of MORC2 with HUSH and SETDB1 in maintaining H3K9me3 across the bodies of ZNF-encoding genes.
The DIVA results suggested that HUSH-target loci normally adopt a compact chromatin state, which must be reversed to alleviate repression. Although repressed genomic regions have canonically been associated with dense chromatin domains that are refractory to the transcription machinery, there may be distinct mechanisms through which such nucleosome compaction is achieved. In particular, the specific requirement for ATP hydrolysis to drive compaction during HUSH-mediated silencing appears to be distinct from the requirements of other key repressive complexes. For example, ATP hydrolysis has not been implicated in heterochromatin formation through the SUV39H1-HP1 axis, another major route to H3K9me3-mediated silencing. Compact heterochromatic structures have also been associated with Polycomb-driven repression 37 , but again this compaction function does not appear to require an ATP motor and has instead been attributed to a disordered region rich in basic amino acids in PRC1 (ref. 38 ). However, ATP-dependent chromatin remodelers have previously been shown to play an indirect role in transcriptional repression by establishing the appropriate nucleosome spacing for subsequent silencing 39 . For example, the nucleosome remodeling deacetylase (NuRD) complex utilizes the chromatin remodeling function of its CHD subunits to space adjacent nucleosomes, thereby making the histone tails accessible for deacetylation 40 . Therefore, one possibility is that MORC2 may be recruited by HUSH and consequently position nucleosomes such that the chromatin is permissive to transcriptional repression.
The mechanism through which dominant mutations in MORC2 cause axonal CMT disease [29] [30] [31] [32] [33] and severe spinal muscular atrophy (SMA)-like disease 41 is unknown. Given that individuals with this disease retain one functional wild-type MORC2 allele, the disease phenotype is unlikely to result from loss of function of the mutant protein. Our data suggested that a gain-of-function effect underlies the phenotype of the MORC2 p.Arg252Trp CMT substitution and results in hyperactivation of HUSH complex function at both exogenous transgenes and endogenous genomic loci. Indeed, the closely related MORC1 protein, which represses transposable elements in the male germ line 21 , contains a tryptophan residue at the equivalent position.
Further work will be required to elucidate the biochemical basis underlying the hyperactivation phenotype resulting from the MORC2 p.Arg252Trp substitution. Structural insight into the organization of the MORC2 ATPase domain would be invaluable in assessing the effects of the p.Arg252Trp substitution and may also guide the rational design of small-molecule inhibitors. Inhibition of Hsp90, the prototypical member of the GHKL family of ATPases, has been successfully achieved by using the small molecules geldanamycin and radicicol 42, 43 , and the latter is also effective against the distantly related GHKL family member SMCHD1 (ref. 44) . Overall, these data suggest that inhibition of the ATPase domain of MORC2 is an attractive target for the therapeutic modulation of HUSH complex function.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. and the supernatant, which contained the cytosolic fraction, was collected. The nuclear pellet was resuspended in buffer B (20 mM HEPES, 1.5 mM MgCl 2 , 300 mM NaCl, 0.5 mM DTT, 25% (vol/vol) glycerol, 0.2 mM EDTA and an EDTA-free protease-inhibitor-cocktail tablet) for 10 min on ice, and, after centrifugation at 1,700g for 4 min at 4 °C, the supernatant (containing the nucleosolic fraction) was removed. The insoluble pellet, constituting the chromatin fraction, was subsequently solubilized in 1% SDS with 1:100 benzonase for 20 min at room temperature.
ChIP-seq. Cells were washed once in PBS, resuspended in growth medium and then cross-linked in 1% formaldehyde for 10 min. The reaction was quenched for 5 min by addition of glycine to a final concentration of 0.125 M, and the cells were lysed in cell lysis solution (1 mM HEPES, 85 mM KCl and 0.5% IGEPAL). Nuclei were pelleted by centrifugation and then resuspended in nuclear lysis solution (5 mM Tris, 10 mM EDTA and 1% SDS) for 10 min. The chromatin was sheared with a Bioruptor (Diagenode; high power, 20 cycles of 30 s on and 30 s off) to obtain a mean fragment size of ~300 bp. Insoluble material was removed by centrifugation. The chromatin solution was precleared with Protein A-Sepharose (Sigma-Aldrich) and then immunoprecipitated overnight with 5 µg primary antibody and Protein A-Sepharose, or, for V5-MORC2, anti-V5 agarose affinity gel (Sigma-Aldrich, A7345). The next day, the beads were washed five times, and bound protein-DNA complexes were eluted in 150 mM NaHCO 3 and 1% SDS. Cross-links were reversed by overnight incubation at 67 °C with 0.3 M NaCl and RNase A. Proteinase K was then added, the samples were incubated for 2 h at 45 °C, and then the DNA was purified with a spin column (Qiagen PCR Purification Kit). Illumina sequencing libraries were produced from this material with a TruSeq ChIP Sample Prep Kit (Illumina), and 50-bp single-end reads were generated on a HiSeq 2500 instrument. Reads were aligned to the human genome (GRCh37) with Bowtie 2, and reads with a MAPQ score >10 were imported into SeqMonk and EaSeq 47 for further analysis. V5-MORC2-binding sites were identified through implementation of the MACS peak caller in SeqMonk (window size, 300 bp; P value <0.0001), and the resulting 4,500 peaks were centered and plotted with the Average Signal Tracks tool in EaSeq. H3K4me3 ChIP-seq data generated by the laboratory of B. Bernstein (Broad Institute) were downloaded from the ENCODE project (ENCSR000AOF). Expression and purification of the CW domain of MORC2. A synthetic Escherichia coli codon-optimized DNA construct (IDT) encoding the MORC2 CW domain (residues 490-546) plus a C-terminal FLAG tag was cloned into the expression vector pET-28a-N-His-SUMO between the BamHI and NotI restriction sites, for production of the N-terminally histidine-SUMO-tagged protein product. Protein was produced in E. coli BL21(DE3) cells through overnight incubation at 18 °C with shaking at 220 r.p.m., after induction with 200 µM IPTG. Cell pellets were resuspended in 30 ml lysis buffer (50 mM Tris-HCl, 500 mM NaCl, 10 mM imidazole, 0.1 mM ZnSO 4 , 1 mM DTT and 1× Complete EDTA-free protease inhibitors, pH 8.0), flash frozen in liquid nitrogen and stored at −80 °C.
Pellets were thawed and further lysed by sonication on ice before clarification by centrifugation (45 min, 40,000g, 4 °C). The resulting histidine-SUMO-CW-FLAG-containing supernatant was subjected to immobilized Ni-NTA affinity chromatography with wash (50 mM Tris-HCl, 500 mM NaCl, 10 mM imidazole, 0.1 mM ZnSO 4 and 1 mM DTT, pH 8.0) and elution (50 mM TrisHCl, 500 mM NaCl, 300 mM imidazole, 0.1 mM ZnSO 4 and 1 mM DTT, pH 8.0) buffers, then desalted with a Bio-Rad Econo-Pac 10DG column into cleavage buffer (20 mM HEPES, 150 mM NaCl, 0.1 mM ZnSO 4 and 1 mM DTT, pH 7.4). The histidine-SUMO tag was cleaved from the protein by the addition of histidine-tagged SENP1 protease (1:10 (wt/wt) for 18 h on ice. Subtractive immobilized Ni-NTA affinity chromatography was then used to deplete the tagged protease and the free histidine-SUMO tag, and the protein was further purified by size-exclusion chromatography on a Superdex 75 (10/300) column in a buffer containing 20 mM HEPES, 200 mM NaCl, 0.1 mM ZnSO 4 and 1 mM TCEP, pH 7.3. The masses of the intact, pure proteins were confirmed with a Waters Xevo G2 Q-ToF mass spectrometer.
Differential viral accessibility (DIVA).
Six million wild-type and MORC2-knockout HeLa cells were seeded at a density of 1 × 10 6 cells per well of a six-well plate and transduced on successive days with the lentiviral vector pHRSIN-P SFFV -mCherry-WPRE (encoding the mCherry fluorescent protein driven by the spleen focus-forming virus LTR promoter) at a high multiplicity of infection, such that ~100% of the cells were positive for mCherry. One day after the second transduction, genomic DNA was extracted (Gentra Puregene Kit) and digested overnight with NlaIII (NEB). The distribution of NlaIII sites in the lentiviral vector was such that DNA fragments smaller than ~1.8 kb could not contain viral-genome junctions; large fragments were therefore enriched through a size-selection step with a 0.5× Agencourt AMPure XP bead clean-up (Beckman Coulter). An annealed dsDNA adaptor with an NlaIII-compatible overhang was then ligated onto the ends of the genomic DNA fragments with T4 DNA Ligase (NEB) overnight at 16 °C, and the ligated products were purified through further AMPure bead cleanup. Virus-genome junctions were then amplified in 200 cycles of a linear PCR reaction with Accuprime Taq (Thermo Fisher Scientific) with a biotinylated primer binding immediately upstream of the 5′ LTR in the integrated provirus, and the resulting products were annealed to streptavidin-coated M-280 Dynabeads (Thermo Fisher Scientific). After five 10-min washes with PBS and 0.1% Tween-20, virus-genome junctions were amplified through 12 cycles of on-bead exponential PCR with an Illumina P5-adapted primer binding the proviral 5′ LTR and a P7-adapted reverse primer binding the splinkerette adaptor. After a final AMPure XP cleanup, PCR products were quantified, pooled and sequenced on an Illumina HiSeq2500 instrument generating 50-bp single-end reads from a custom primer annealing to the extreme end of the proviral 5′ LTR. All oligonucleotide sequences are detailed in Supplementary Table 3 .
The resulting sequence reads were trimmed of adaptor sequences with the fastx toolkit and aligned to the human genome (hg19) with Bowtie 2. Reads with a MAPQ score >10 were imported into SeqMonk and converted into a set of unique points of integration. The Intensity Difference Filter in Seqmonk was used to identify 10-kb genomic windows (overlapping by 5 kb) significantly enriched in lentiviral integration sites in MORC2-knockout cells compared with the parental wild-type cells; individual loci were considered to exhibit decompaction only if at least two adjacent windows reached statistical significance. Full data for all genomic loci are provided in Supplementary Table 2. Micrococcal nuclease accessibility assay. Wild-type and MORC2-knockout HeLa cells were washed once in PBS, resuspended in growth medium, and then cross-linked by the addition of 1% formaldehyde for 10 min. The reaction was quenched by addition of glycine to a final concentration of 0.125 M for 5 min. The cells were then lysed in cell lysis solution (1 mM HEPES, 85 mM KCl and 0.5% IGEPAL), and nuclei were pelleted by centrifugation (800g, 5 min, 4 °C). The nuclei (5 × 10 5 per reaction) were then resuspended in micrococcal nuclease buffer supplemented with BSA (NEB), and chromatin was digested by the addition of 2 U micrococcal nuclease (NEB) for 30 min at 37 °C. EDTA was added to a final concentration of 45 mM to stop the reaction. Nuclei were then lysed in 1% SDS, RNA was digested with RNase A (37 °C for 30 min), and cross-links were reversed overnight at 65 °C. Proteins were then digested with proteinase K (37 °C for 2 h), and DNA was isolated by phenolchloroform extraction and subsequent ethanol precipitation. Size selection of the digested DNA was achieved with SPRIselect beads (Beckman Coulter) with a 0.6× volume of beads. The bound fraction contained large fragments (>~1,000 bp); the supernatant containing unbound fragments (<~1,000 bp) was removed and subsequently purified through the addition of an additional 1× volume of beads. The amount of DNA from target loci in the accessible and inaccessible fractions compared with the pre-size-selected starting material was measured by qPCR performed on a CFX96 Touch Real-Time PCR machine (Bio-Rad) with iTaq Universal SYBR Green Supermix (Bio-Rad) in a final reaction volume of 25 µl. Thermal cycling parameters were 50 °C for
